Future developments in XLHED treatment approaches

American Journal of Medical Genetics, Part A

Volumn 164, Issue 10, 2014, Pages 2433-2436

  Huttner, Kenneth ^a  

^a Edimer Pharmaceuticals Inc   (United States)

Author keywords

Animal models; Ectodermal dysplasia; Protein therapeutic

Indexed keywords

ECTODYSPLASIN A; ECTODYSPLASIN A1; EDAR RECEPTOR; EDI 200; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

DEVELOPMENTAL DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ECTODERM; EDA GENE; GENE; GENE DELETION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOHIDROTIC ECTODERMAL DYSPLASIA; MISSENSE MUTATION; NEWBORN PERIOD; NONHUMAN; POSTNATAL CARE; PRENATAL CARE; REVIEW; ANIMAL; ECTODERMAL DYSPLASIA; GENETICS; PHENOTYPE;

ANIMALS; ECTODERMAL DYSPLASIA; ECTODYSPLASINS; HUMANS; PHENOTYPE;

EID: 84908258351     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36499     Document Type: Review

References (19)

1. Beahrs JO, Lillington GA, Rosan RC, Russin L, Lindgren JA, Rowley PT. 1971. Anhidrotic ectodermal dysplasia: Predisposition to Bronchial Disease. Ann Int Med 14:92-96.
2. Beck MJ, Padgett EL, Parker GA, Maginnis GM, Toot JD, Varsho BJ, Varsho JS. 2012. Nonclinical juvenile toxicity testing. In: Hood RD, editor. Developmental and reproductive toxicology, a practical approach, 3rd edition. London: Informa Healthcare. pp 302-345.
3. Casal ML, Scheidt JL, Rhodes JL, Henthorn PS, Werner P. 2005. Mutation identification in a canine model of X-linked ectodermal dysplasia. Mamm Genome 16:524-531.
4. Casal ML, Lewis JR, Mauldin EA, Tardivel A, Ingold K, Favre M, Paradies F, Demotz S, Gaide O, Schneider P. 2007. Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia. Am J Hum Genet 81:1050-1056.
5. Clarke A, Phillips D, Brown R, Harper P. 1987. Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child 62:989-996.
6. Ferguson BM, BrockdorffN, Formstone E, Nguyne T, Kronmiller JE, Zonana J. 1997. Cloning of Tabby, the murine homolog of the human EDA protein: Evidence for a membrane-asociated protein with a short collagenous domain. Hum Mol Genet 6:1589-1594.
7. Gaide O, Schneider P. 2003. Permanent correction of an inherited ectodermal dysplasia with recombinant EDA. Nat Med 9:614-618.
8. Hoath SB, Maibach HI, editors. 2003. Neonatal skin, structure and function, 2nd edition, revised and expanded. New York: Marcel Dekker, Inc. 371 p.
9. Kere J, Srivastava AK, Montonen O, Zonana J, Thomas N, Ferguson B, Munoz F, Morgan D, Clarke A, Baybayan P, Chen EY, Ezer S, Saarialho-Kere U, de la Chapelle A, Schlessinger D. 1996. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet 13:409-416.
10. Mauldin EA, Gaide O, Schneider P, Casal ML. 2009. Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia. Am J Med Genet Part A 149A:2045-2049.
11. Monreal AW, Zonana J, Ferguson B. 1998. Identification of a new splice form of the EDA1 gene permits detection of nearly all X-linked hypohidrotic ectodermal dysplasia mutations. Am J Hum Genet 63:380-389.
12. Moore KL. 1982. The developing human, clinically oriented embryology, 3rd edition. Philadelphia: W. B. Saunders Co; 479 p.
13. Pinheiro M, Freire-Maia N. 1979. Christ-Siemens-Touraine syndrome-A clinical and genetic analysis of a large Brazilian kindred: II. Affected males. Am J Med Genet 4:123-128.
14. Rouse C, Siegfried E, Breer W, Nahass G. 2004. Hair and sweat glands in families with hypohidrotic ectodermal dysplasia: Further characterization. Arch Derm 140:850-855.
15. Schneider P, Street SL, Gaide O, Hertig S, Tardivel A, Tschopp J, Runkel L, Alevizopoulos A, Ferguson BM, Zonana J. 2001. Mutations leading to Xlinked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A. J Biol Chem 276:18819-18827.
16. Srivastava AK, Pispa J, Hartung AJ, Du Y, Ezer S, Jenks T, Shiumada T, Pekkanen M, Mikkola ML, Ko MSH, ThesleffI, Kere J, Schlessinger D. 1997. The Tabby phenotype is caused by mutation in a mouse homologue of the EDA gene that reveals novel mouse andhumanexons and encodes a protein (ectodysplasin-A) with collagenous domains. Proc Natl Acad Sci USA 94:13069-13074.
17. Srivastava AK, Durmowicz MC, Hartung AJ, Hudson J, Ouzts LV, Donovan DM, Cui CY, Schlessinger D. 2001. Ectodysplasin-A1 is sufficient to rescue both hair growth and sweat glands in Tabby mice. Hum Mol Genet 10:2973-2981.
18. Tso MS, Crawford PJ, Miller J. 1985. Hypodontia, ectodermal dysplasia and sweat pore count. Brit Dent J 158:56-60.
19. Zonana J, Clarke A, Sarfarazi M, Thomas NST, Roberts K, Marymee K, Harper PS. 1988. X-linked hypohidrotic ectodermal dysplasia: Locatization within the region Xq 11-21. 1 by linkage analysis and implications for carrier detection and prenatal diagnosis. Am J Hum Genet 43:075-085.